These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23669721)

  • 1. Can SLC19A1 80G>A polymorphisms predict risk of extremely delayed MTX excretion after high dose of methotrexate?
    Rasmussen MM; Christensen RH; Gregers J; Heldrup J; Nersting J; Schmiegelow K
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):417-8. PubMed ID: 23669721
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.
    Shimasaki N; Mori T; Torii C; Sato R; Shimada H; Tanigawara Y; Kosaki K; Takahashi T
    J Pediatr Hematol Oncol; 2008 May; 30(5):347-52. PubMed ID: 18458567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a microRNA binding site polymorphism in SLC19A1 on methotrexate concentrations in Chinese children with acute lymphoblastic leukemia.
    Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL
    Med Oncol; 2014 Jul; 31(7):62. PubMed ID: 24927955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC19A1 hot spot for MTX plasma concentration.
    Gutierrez-Camino A; Lopez-Lopez E; Garcia-Orad A
    Med Oncol; 2014 Oct; 31(10):204. PubMed ID: 25178938
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis.
    He HR; Liu P; He GH; Dong WH; Wang MY; Dong YL; Lu J
    Leuk Lymphoma; 2014 Dec; 55(12):2793-800. PubMed ID: 24597986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between methylation level of the
    Huang X; Hao Q; Fang Q; Zhang P; Wei H; Wang Y; Wang J; Mi Y
    Pharmacogenomics; 2023 Apr; 24(5):261-268. PubMed ID: 36999405
    [No Abstract]   [Full Text] [Related]  

  • 7. MiR-595 Suppresses the Cellular Uptake and Cytotoxic Effects of Methotrexate by Targeting SLC19A1 in CEM/C1 Cells.
    Wang SM; Sun LL; Wu WS; Yan D
    Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):8-13. PubMed ID: 29345051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation analysis of the SLC19A1 promoter region in Chinese children with acute lymphoblastic leukaemia.
    Wang SM; Li M; Wu WS; Sun LL; Yan D
    J Clin Pharm Ther; 2020 Aug; 45(4):646-651. PubMed ID: 32403197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia.
    Gervasini G; de Murillo SG; Jiménez M; de la Maya MD; Vagace JM
    Gene; 2017 Sep; 628():72-77. PubMed ID: 28710036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients.
    Lima A; Bernardes M; Sousa H; Azevedo R; Costa L; Ventura F; Seabra V; Medeiros R
    Pharmacogenomics; 2014 Apr; 15(6):807-20. PubMed ID: 24350725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solute Carrier Family 19, member 1 (SLC19A1) polymorphisms (-43T>C, 80G>A, and 696C>T), and haplotypes in idiopathic recurrent spontaneous abortion in a Korean population.
    Rah H; Choi YS; Jeon YJ; Choi Y; Cha SH; Choi DH; Ko JJ; Shim SH; Kim NK
    Reprod Sci; 2012 May; 19(5):513-9. PubMed ID: 22344739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia.
    Iparraguirre L; Gutierrez-Camino A; Umerez M; Martin-Guerrero I; Astigarraga I; Navajas A; Sastre A; Garcia de Andoin N; Garcia-Orad A
    Pharmacogenet Genomics; 2016 Nov; 26(11):517-525. PubMed ID: 27649261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.
    Lopez-Lopez E; Ballesteros J; Piñan MA; Sanchez de Toledo J; Garcia de Andoin N; Garcia-Miguel P; Navajas A; Garcia-Orad A
    Pharmacogenet Genomics; 2013 Feb; 23(2):53-61. PubMed ID: 23222202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients.
    Bohanec Grabar P; Leandro-García LJ; Inglada-Pérez L; Logar D; Rodríguez-Antona C; Dolžan V
    Pharmacogenomics; 2012 Nov; 13(14):1583-94. PubMed ID: 23148635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia.
    Salazar J; Altés A; del Río E; Estella J; Rives S; Tasso M; Navajas A; Molina J; Villa M; Vivanco JL; Torrent M; Baiget M; Badell I
    Pharmacogenomics J; 2012 Oct; 12(5):379-85. PubMed ID: 21747412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number.
    Gregers J; Christensen IJ; Dalhoff K; Lausen B; Schroeder H; Rosthoej S; Carlsen N; Schmiegelow K; Peterson C
    Blood; 2010 Jun; 115(23):4671-7. PubMed ID: 20335220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.
    Chiusolo P; Giammarco S; Bellesi S; Metafuni E; Piccirillo N; De Ritis D; Marietti S; Federica S; Laurenti L; Fianchi L; Hohaus S; Giuseppe L; Sica S
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):691-6. PubMed ID: 21984221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Association Study of the SLC19A1 Gene Polymorphisms/Haplotypes with Idiopathic Recurrent Pregnancy Loss in an Iranian Population.
    Mohtaram S; Sheikhha MH; Honarvar N; Sazegari A; Maraghechi N; Feizollahi Z; Ghasemi N
    Genet Test Mol Biomarkers; 2016 May; 20(5):235-40. PubMed ID: 26959650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism G80A in the reduced folate carrier gene and its relationship to survival and risk of relapse in acute lymphoblastic leukemia.
    Leyva-Vázquez MA; Organista-Nava J; Gómez-Gómez Y; Contreras-Quiroz A; Flores-Alfaro E; Illades-Aguiar B
    J Investig Med; 2012 Oct; 60(7):1064-7. PubMed ID: 22914600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.